News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Checkmate Pharmaceuticals
NEWS
IN THE PRESS
NEWS
Checkmate Pharmaceuticals was acquired by Regeneron in 2022.
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
·
15 min read
·
Mark Terry
Business
What You Need to Know About Checkmate
December 2, 2015
·
6 min read
Business
Checkmate Comes Out of Stealth Mode With $20 Million and Ex-Sarepta Exec as Its Leader
August 12, 2015
·
3 min read
AWARDS
IN THE PRESS
Drug Development
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Multi-Indication Trial Using Vidutolimod
December 20, 2021
·
5 min read
Genetown
Checkmate Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 15, 2021
·
4 min read
Business
Checkmate Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update
November 12, 2021
·
8 min read
Drug Development
Checkmate Pharmaceuticals Presents Final Clinical Data for Phase 1b Study Evaluating Vidutolimod at The Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 12, 2021
·
8 min read
Genetown
Checkmate Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 11, 2021
·
4 min read
Genetown
Checkmate Pharmaceuticals Announces Final Data Presentation for Phase 1b Study Evaluating Vidutolimod at The Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 1, 2021
·
4 min read
Business
Checkmate Pharmaceuticals Announces CEO TransitionAlan Fuhrman, experienced biotech executive and Checkmate board member, appointed as interim President and CEO
October 27, 2021
·
5 min read
Genetown
Checkmate Pharmaceuticals Announces Webcast on Innate Immune Modulators and Vidutolimod (CMP-001)
October 20, 2021
·
5 min read
Genetown
Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
September 14, 2021
·
4 min read
Genetown
Checkmate Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 7, 2021
·
4 min read
